HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antiarrhythmic action of bethanidine.

Abstract
Studies were performed in 20 patients with symptomatic ventricular tachycardia (VT) to determine the efficacy of bethanidine compared with procainamide in preventing VT induced by programmed electrical stimulation. Before administering bethanidine, 5 to 10 mg/kg, the patients received 15 mg of protriptyline orally 24 and 2 hours before electrophysiologic studies to prevent the orthostatic hypotensive effects of bethanidine. Sustained VT (VT not spontaneously stopping) was induced in 8 and nonsustained VT (10 beats or more, terminating spontaneously) was induced in 4 patients. Bethanidine, 5 mg/kg, protected in 7 patients, and 10 mg/kg protected 1 additional patient. Procainamide, 1,000 and 1,500 mg intravenously, protected 8 of 16 patients. Bethanidine prevented VT induction in 50% of the patients not protected by procainamide. Bethanidine facilitated VT induction in 3 patients, while procainamide facilitated VT induction in 1 patient. Four patients with symptomatic VT have received bethanidine therapy for an average of 11 +/- 1.3 months, without clinical recurrence of their VT. Concomitant administration of protriptyline attenuated the acute hemodynamic changes caused by bethanidine and chronic combined therapy of protriptyline and bethanidine abolished the severe orthostatic changes in blood pressure caused by bethanidine. These studies show that bethanidine is effective in preventing VT induction and, thus, its use may not be restricted only to cases of primary ventricular fibrillation.
AuthorsJ C Somberg, B Butler, V Torres, D Flowers, D Tepper, J Wynn, G Keren, D S Miura
JournalThe American journal of cardiology (Am J Cardiol) Vol. 54 Issue 3 Pg. 343-6 (Aug 01 1984) ISSN: 0002-9149 [Print] United States
PMID6465015 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Guanidines
  • Protriptyline
  • Procainamide
  • Bethanidine
Topics
  • Bethanidine (adverse effects, therapeutic use)
  • Blood Pressure (drug effects)
  • Cardiac Pacing, Artificial
  • Electrocardiography
  • Female
  • Guanidines (therapeutic use)
  • Heart Ventricles
  • Humans
  • Hypotension, Orthostatic (chemically induced, prevention & control)
  • Male
  • Middle Aged
  • Procainamide (adverse effects, therapeutic use)
  • Protriptyline (therapeutic use)
  • Tachycardia (drug therapy, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: